Negative Mode Analysis of Synthetic Oligonucleotides using the MALDI-8030 Dual Polarity Benchtop MALDI-TOF Mass Spectromet
Applications | 2022 | ShimadzuInstrumentation
Synthetic oligonucleotides are central tools in molecular biology, diagnostics and therapeutic development. Rapid and reliable genotyping of DNA fragments, such as mutations in the CFTR gene causing cystic fibrosis, is crucial for clinical screening, research and teaching laboratories. Adapting MALDI-TOF mass spectrometry for oligonucleotide analysis offers a faster, less labor‐intensive alternative to traditional gel‐based methods.
This application note evaluates the performance of the MALDI-8030 dual polarity benchtop linear MALDI-TOF mass spectrometer for genotyping synthetic oligonucleotides in negative ion mode. Using the common Phe508del CFTR mutation as a model system, the study compares negative vs positive ion detection, examines adduct formation, and demonstrates the ability to distinguish wild type, homozygous mutant and heterozygous samples.
The study employed:
Oligonucleotides were prepared at 100 µM and mixed 1:2 with matrix prior to spotting. Negative mode analyses were performed without desalting, while positive mode samples underwent ion‐exchange cleanup.
Negative ion mode spectra displayed clean [M–H]⁻ peaks at m/z 3656.43 (wild type) and m/z 2758.85 (mutant) with excellent mass accuracy. In contrast, positive mode spectra required desalting and still exhibited minor Na⁺/K⁺ adducts. The dual polarity MALDI-8030 resolved all three genotypes: wild type, homozygote and heterozygote, enabling clear mass separation and reliable genotyping without gel electrophoresis.
Advances in benchtop MALDI-TOF instrumentation and matrix chemistries may further improve sensitivity and resolution for longer or modified oligonucleotides. Multiplexed analyses and automated sample preparation could extend applications to high-volume genotyping, next-generation sequencing fragment analysis, and diagnostic panels for diverse genetic disorders.
The MALDI-8030 in negative ion mode offers a streamlined, accurate and cost‐effective workflow for oligonucleotide genotyping. By avoiding desalting and adduct formation, it provides a robust alternative to gel‐based methods, suitable for both educational and routine clinical research settings.
1. Hakkak AM, et al. Iranian Journal of Basic Medical Sciences. 2013;16(8):917.
2. Ferrie RM, et al. Am J Hum Genet. 1992;51(2):251.
3. Frenţescu L, et al. J Cyst Fibros. 2008;7(5):423–428.
4. Ncbi.Nlm.Nih.Gov. Restriction Fragment Length Polymorphism (RFLP). 2021.
5. Srinivasan S, Batra J. Single Nucleotide Polymorphism Typing. 2019:432–440.
6. Peng BY, et al. Acta Pharmacologica Sinica. 2018;39(1):117–123.
MALDI, LC/TOF, LC/MS
IndustriesProteomics
ManufacturerShimadzu
Summary
Importance of the topic
Synthetic oligonucleotides are central tools in molecular biology, diagnostics and therapeutic development. Rapid and reliable genotyping of DNA fragments, such as mutations in the CFTR gene causing cystic fibrosis, is crucial for clinical screening, research and teaching laboratories. Adapting MALDI-TOF mass spectrometry for oligonucleotide analysis offers a faster, less labor‐intensive alternative to traditional gel‐based methods.
Objectives and study overview
This application note evaluates the performance of the MALDI-8030 dual polarity benchtop linear MALDI-TOF mass spectrometer for genotyping synthetic oligonucleotides in negative ion mode. Using the common Phe508del CFTR mutation as a model system, the study compares negative vs positive ion detection, examines adduct formation, and demonstrates the ability to distinguish wild type, homozygous mutant and heterozygous samples.
Methodology and Used Instrumentation
The study employed:
- MALDI-8030 Dual Polarity Benchtop Linear MALDI-TOF (Shimadzu)
- 3-Hydroxypicolinic acid (3-HPA) MALDI matrix with ammonium citrate dibasic
- Dowex® cation exchange resin for desalting in positive mode
- Synthetic oligonucleotides (Merck): ATCTTTGGTGTT (wild type), ATTGGTGTT (Phe508del mutant)
Oligonucleotides were prepared at 100 µM and mixed 1:2 with matrix prior to spotting. Negative mode analyses were performed without desalting, while positive mode samples underwent ion‐exchange cleanup.
Main results and discussion
Negative ion mode spectra displayed clean [M–H]⁻ peaks at m/z 3656.43 (wild type) and m/z 2758.85 (mutant) with excellent mass accuracy. In contrast, positive mode spectra required desalting and still exhibited minor Na⁺/K⁺ adducts. The dual polarity MALDI-8030 resolved all three genotypes: wild type, homozygote and heterozygote, enabling clear mass separation and reliable genotyping without gel electrophoresis.
Benefits and practical applications
- Elimination of desalting steps and adduct interferences
- High throughput screening of PCR products
- Reduced analysis time compared to gel electrophoresis and ethidium bromide detection
- Enhanced teaching laboratory workflows for student training
- Potential integration into routine genotyping laboratories
Future trends and potential applications
Advances in benchtop MALDI-TOF instrumentation and matrix chemistries may further improve sensitivity and resolution for longer or modified oligonucleotides. Multiplexed analyses and automated sample preparation could extend applications to high-volume genotyping, next-generation sequencing fragment analysis, and diagnostic panels for diverse genetic disorders.
Conclusion
The MALDI-8030 in negative ion mode offers a streamlined, accurate and cost‐effective workflow for oligonucleotide genotyping. By avoiding desalting and adduct formation, it provides a robust alternative to gel‐based methods, suitable for both educational and routine clinical research settings.
References
1. Hakkak AM, et al. Iranian Journal of Basic Medical Sciences. 2013;16(8):917.
2. Ferrie RM, et al. Am J Hum Genet. 1992;51(2):251.
3. Frenţescu L, et al. J Cyst Fibros. 2008;7(5):423–428.
4. Ncbi.Nlm.Nih.Gov. Restriction Fragment Length Polymorphism (RFLP). 2021.
5. Srinivasan S, Batra J. Single Nucleotide Polymorphism Typing. 2019:432–440.
6. Peng BY, et al. Acta Pharmacologica Sinica. 2018;39(1):117–123.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Negative Mode Analysis of Synthetic Oligonucleotides using the MALDI-8030 Dual Polarity Benchtop MALDI-TOF Mass Spectrometer
2022|Shimadzu|Applications
MALDI-TOF Mass Spectrometry Analysis Application News MALDI-8030 Negative Mode Analysis of Synthetic Oligonucleotides using the MALDI-8030 Dual Polarity Benchtop MALDI-TOF Mass Spectrometer S. Salivo User Benefits Simple analysis of oligonucleotides, in negative ion mode to reduce adducts, on an…
Key words
cftr, cftrprimer, primerethidium, ethidiumhomozygote, homozygoteallele, allelewild, wildheterozygote, heterozygotenegative, negativegene, geneoligonucleotides, oligonucleotidesmode, modepcr, pcrgel, gelnormal, normalelectrophoresis
Dual-Polarity Benchtop Linear MALDI-TOF Mass Spectrometer - MALDI-8030
2024|Shimadzu|Brochures and specifications
MO473 Dual-Polarity Benchtop Linear MALDI-TOF Mass Spectrometer MALDI-8030 AFFORDABLE CLASSBest-in-class sensitivity and resolution • Easily detect analytes for your application Award-winning design • Based on the award-winning MALDI-8020 design Innovative electronics • Fast, high bit-depth transient recorder provides rapid data…
Key words
intensity, intensitymaldi, malditrueclean, truecleanevoo, evoolaser, laserdual, dualpolarity, polarityyour, yourbenchtop, benchtopaurasolution, aurasolutionintact, intactfleximass, fleximassmass, massmisidentification, misidentificationemstat
Oligonucleotide Therapeutics Solution Guide
2025|Shimadzu|Guides
C10G-E097 Oligonucleotide Therapeutics Solution Guide Types and Characteristics of Oligonucleotide Therapeutics Oligonucleotide therapeutics are nucleic acid polymers generally comprised of a few to several dozen bases However, it is a practical problem that oligonucleotide therapeutics are degraded and excreted rapidly…
Key words
excision, excisiondds, ddsunprotected, unprotectedcharacteristic, characteristicindex, indexoligomer, oligomerpharmacokinetics, pharmacokineticsquality, qualitycontrol, controlsynthesis, synthesisoligonucleotide, oligonucleotidepurification, purificationmodification, modificationtorast, torastanalysis
Gene Therapy and Oligonucleotide Compendium - Volume 1
2020|SCIEX|Guides
Gene Therapy and Oligonucleotide Compendium Volume 1 Gene Therapy and Oligonucleotide Compendium Contents Introduction 4 Growing trends and emerging technologies for oligonucleotide and gene therapies 6 The global gene therapy & oligonucleotide market 8 Regional landscape North America EMEAI (Europe,…
Key words
gene, genetherapy, therapyoligonucleotide, oligonucleotidesciex, sciexcompendium, compendiumcontents, contentsdownload, downloadgexp, gexptechnical, technicalexpression, expressionprimer, primerdna, dnaplasmid, plasmidnote, noteaav